XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
1.310
+0.040 (3.15%)
Apr 22, 2025, 1:03 PM EDT - Market open
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $10.97 million as of April 22, 2025. Its market cap has decreased by -3.40% in one year.
Market Cap
10.97M
Enterprise Value
9.24M
1-Year Change
-3.40%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since August 31, 2005, XTL Biopharmaceuticals's market cap has decreased from $179.98M to $10.97M, a decrease of -93.91%. That is a compound annual growth rate of -13.27%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.44B |
| UnitedHealth Group | 387.66B |
| Johnson & Johnson | 377.55B |
| AbbVie | 306.90B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 227.66B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |